Upgrade to SI Premium - Free Trial

Celldex Therapeutics (CLDX) PT Raised to $54 at Wells Fargo

May 13, 2026 6:04 AM
Wells Fargo analyst Derek Archila raised the price target on Celldex Therapeutics (NASDAQ: CLDX) to $54.00 (from $38.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change